News & Announcements
-
Result of AGM
/**/ RNS Number : 2442N IQ-AI Limited 30 May 2022 30 May 2022 IQ-AI Limited (“IQ-AI” or the “Company”) Result of AGM IQ-AI Limited announces that at the annual general meeting of the Company held earlier today, all resolutions were duly passed. The Directors of the Company accept responsibility for…
-
Notice of AGM
/**/ RNS Number : 4440K IQ-AI Limited 05 May 2022 5 May 2022 IQ-AI Ltd (“IQ-AI” or the “Company”) Notice of AGM IQ-AI Limited announces that notice of the annual general meeting of the Company, to be held at Third Floor, Forum 4, Grenville Street, St Helier, Jersey, JE2 4UF on…
-
IB Broadens Quantitative Mapping
/**/ RNS Number : 1476K IQ-AI Limited 03 May 2022 3 May 2022 IQ-AI Ltd (“IQ-AI” or the “Company”) IB Neuro’s Quantitative Mapping Method Assesses Metastatic Tumors Study Shows DSC MRI Perfusion Distinguishes Tumor from Non-Tumor Tissue Milwaukee – 3 May 2022: Imaging Biometrics, LLC (IB), a subsidiary of IQ-AI Limited, (OTCQB:…
-
Final Results
/**/ RNS Number : 7683J IQ-AI Limited 28 April 2022 28 April 2022 IQ-AI Ltd (“IQ-AI”, the “Company” and, together with its subsidiaries, the “Group”) Publication of Annual Report The Board of IQ-AI Ltd are pleased to present announce that the Company’s audited financial statements for the year ended 31 December 2021.…
-
IQAI’s Sponsored Phase 1 Clinical Trial is Open
/**/ RNS Number : 2319E IQ-AI Limited 09 March 2022 FOR IMMEDIATE RELEASE IQ-AI LIMITED (“IQ-AI” or the “Company”) IQAI’s Sponsored Phase I Clinical Trial is Open Milwaukee – 9 March 2022: IQ-AI Limited (OTCQB: IQAIF) (LSE: IQAI) is pleased to announce that the sponsored Phase I clinical trial for oral gallium maltolate (GaM)…